SH3PXD2A Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the SH3PXD2A antibody detected the SH3PXD2A protein (arrow).
SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5; SH3 and PX domain-containing protein 2A; Adapter protein TKS5; Five SH3 domain-containing protein; SH3 multiple domains protein 1; Tyrosine kinase substrate with five SH3 domains
Key Feature
Clonality
Polyclonal
Isotype
Ig
Host Species
Rabbit
Tested Applications
WB
WB:1:100~500
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Gene Synonyms
FISH KIAA0418 SH3MD1 TKS5
Alternative Names
SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 SH3 and PX domain-containing protein 2A Adapter protein TKS5 Five SH3 domain-containing protein SH3 multiple domains protein 1 Tyrosine kinase substrate with five SH3 domains
Molecular Weight(MW)
125289 Da
Function
Adapter protein involved in invadopodia and podosome formation, extracellular matrix degradation and invasiveness of some cancer cells. Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. In association with ADAM12, mediates the neurotoxic effect of beta-amyloid peptide
Tissue Specificity
Found in several cancer cell lines, particularly invasive breast carcinomas and melanomas
Cellular Localization
Cytoplasm. Cell projection, podosome. Note=Cytoplasmic in normal cells and localizes to podosomes in SRC-transformed cells
SH3PXD2A Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the SH3PXD2A antibody detected the SH3PXD2A protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.